These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30723410)

  • 21. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism.
    Yaffe MB; Schutkowski M; Shen M; Zhou XZ; Stukenberg PT; Rahfeld JU; Xu J; Kuang J; Kirschner MW; Fischer G; Cantley LC; Lu KP
    Science; 1997 Dec; 278(5345):1957-60. PubMed ID: 9395400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational perspective and evaluation of plausible catalytic mechanisms of peptidyl-prolyl cis-trans isomerases.
    Ladani ST; Souffrant MG; Barman A; Hamelberg D
    Biochim Biophys Acta; 2015 Oct; 1850(10):1994-2004. PubMed ID: 25585011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pinning Down the Transcription: A Role for Peptidyl-Prolyl
    Hu X; Chen LF
    Front Cell Dev Biol; 2020; 8():179. PubMed ID: 32266261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Pin1 expression is associated with tumor progression in colorectal cancer.
    Kuramochi J; Arai T; Ikeda S; Kumagai J; Uetake H; Sugihara K
    J Surg Oncol; 2006 Aug; 94(2):155-60. PubMed ID: 16847925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human PIN1 peptidyl-prolyl cis/trans isomerase gene maps to human chromosome 19p13 and the closely related PIN1L gene to 1p31.
    Campbell HD; Webb GC; Fountain S; Young IG
    Genomics; 1997 Sep; 44(2):157-62. PubMed ID: 9299231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
    Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multisite phosphorylation of Pin1-associated mitotic phosphoproteins revealed by monoclonal antibodies MPM-2 and CC-3.
    Albert AL; Lavoie SB; Vincent M
    BMC Cell Biol; 2004 Jun; 5():22. PubMed ID: 15171797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIN1 in Cell Cycle Control and Cancer.
    Cheng CW; Tse E
    Front Pharmacol; 2018; 9():1367. PubMed ID: 30534074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PIN1 in hepatocellular carcinoma is associated with TP53 gene status.
    Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS
    Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Unexpected roles of the peptidyl-prolyl cis/trans isomerase Pin1].
    Lavoie SB; Albert AL; Vincent M
    Med Sci (Paris); 2003 Dec; 19(12):1251-8. PubMed ID: 14691750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.
    Lee TH; Pastorino L; Lu KP
    Expert Rev Mol Med; 2011 Jun; 13():e21. PubMed ID: 21682951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
    Finn G; Lu KP
    Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
    Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G
    Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α.
    Han HJ; Kwon N; Choi MA; Jung KO; Piao JY; Ngo HK; Kim SJ; Kim DH; Chung JK; Cha YN; Youn H; Choi BY; Min SH; Surh YJ
    PLoS One; 2016; 11(1):e0147038. PubMed ID: 26784107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction and structural modification of topoisomerase IIalpha by peptidyl prolyl isomerase, pin1: an in silico study.
    Mathur R; Suman S; Beaume N; Ali M; Bhatt AN; Chopra M; Saluja D; Mishra AK; Chandna S; Kapoor PN; Dwarakanath BS
    Protein Pept Lett; 2010 Feb; 17(2):151-63. PubMed ID: 20214639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin.
    Cheng CW; Chow AK; Pang R; Fok EW; Kwong YL; Tse E
    Am J Pathol; 2013 Mar; 182(3):765-75. PubMed ID: 23333752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association.
    Hwang YC; Yang CH; Lin CH; Ch'ang HJ; Chang VHS; Yu WCY
    Biochim Biophys Acta; 2013 Dec; 1833(12):3035-3045. PubMed ID: 23994618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.
    Driver JA; Zhou XZ; Lu KP
    Biochim Biophys Acta; 2015 Oct; 1850(10):2069-76. PubMed ID: 25583562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration.
    Rudrabhatla P; Pant HC
    J Alzheimers Dis; 2010; 19(2):389-403. PubMed ID: 20110589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.